First, we found that the serum MIC-1 level of patients with PDAC is significantly higher than that of healthy controls, benign pancreas tumors and chronic pancreatitis populations, indicating that MIC-1 may serve as a promising biomarker in diagnosis of PDAC. This evidence concerns the gene GDF15 and benign neoplasm of pancreas.